Literature DB >> 30574322

Modified prophylactic 5-fr pancreatic duct stent enhances the rate of spontaneous dislodgement: A multicenter randomized controlled trial.

Qibin He1,2, Lei Wang1,2, Chunyan Peng1,2, Xiaoping Zou1,2, Qiang Zhan3, Yaping Xu4, Qiang Liu5, Junbo Qian6, Lei Gong7, Yingzhou Shen8, Jianping Chen9.   

Abstract

BACKGROUND AND OBJECTIVES: Prophylactic pancreatic duct stent placement effectively reduces post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients, but the optimal stent remains unclear. We modified a 5-Fr, 3 cm pancreatic stent by removing the flange on the pancreatic side and compared the rate of spontaneous dislodgement and complications with the ordinary stent.
METHODS: This was a randomized controlled trial at six tertiary endoscopic centers. Patients deemed high risk for post-endoscopic retrograde cholangiopancreatography pancreatitis randomly received modified or ordinary pancreatic stent. The primary outcome was spontaneous stent dislodgement at five days and 14 days. Secondary outcomes were the success rate of stent placement and complications.
RESULTS: A total of 276 patients were randomly assigned to receive modified stents (mS group) and ordinary stents (oS group). The placement of a pancreatic stent was successful in all 276 patients. There were no significant differences between groups with respect to age, sex, major diagnosis, or indications for stenting. At five days the spontaneous dislodgement rate was 47.72% for the mS group and 15.67% for the oS group (p<0.001); at 14 days the rates were 84.21% and 42.65%, respectively (p < 0.001). Post-endoscopic retrograde cholangiopancreatography pancreatitis occurred in 6.52% of all patients. There were no significant differences regarding the incidences of post-endoscopic retrograde cholangiopancreatography pancreatitis, hemorrhage or fever.
CONCLUSIONS: The modified short 5-Fr stent has a higher spontaneous dislodgement rate than ordinary pancreatic stent, thus obviating the need for endoscopic removal. The modified pancreatic stent does not increase the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis or other complications. The endoscopist can consider removing the flange on the pancreatic duct side for prophylactic pancreatic duct manipulation.

Entities:  

Keywords:  Pancreatic duct stent; endoscopic retrograde cholangiopancreatography; modified stents; post-endoscopic retrograde cholangiopancreatography pancreatitis; spontaneous dislodgement

Year:  2018        PMID: 30574322      PMCID: PMC6297921          DOI: 10.1177/2050640618804729

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  21 in total

Review 1.  Prevention of post-ERCP pancreatitis: a comprehensive review.

Authors:  Martin L Freeman; Nalini M Guda
Journal:  Gastrointest Endosc       Date:  2004-06       Impact factor: 9.427

2.  Issues in outcomes research: an overview of randomization techniques for clinical trials.

Authors:  Minsoo Kang; Brian G Ragan; Jae-Hyeon Park
Journal:  J Athl Train       Date:  2008 Apr-Jun       Impact factor: 2.860

3.  Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones.

Authors:  T Aizawa; N Ueno
Journal:  Gastrointest Endosc       Date:  2001-08       Impact factor: 9.427

4.  Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis.

Authors:  Ananya Das; Pankaj Singh; Michael V Sivak; Amitabh Chak
Journal:  Gastrointest Endosc       Date:  2007-02-28       Impact factor: 9.427

5.  Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study.

Authors:  Ali Fazel; Affan Quadri; Marc F Catalano; Scott M Meyerson; Joseph E Geenen
Journal:  Gastrointest Endosc       Date:  2003-03       Impact factor: 9.427

6.  Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Prabhleen Chahal; Paul R Tarnasky; Bret T Petersen; Mark D Topazian; Michael J Levy; Christopher J Gostout; Todd H Baron
Journal:  Clin Gastroenterol Hepatol       Date:  2009-05-15       Impact factor: 11.382

7.  Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials.

Authors:  Pankaj Singh; Ananya Das; Gerard Isenberg; Richard C K Wong; Michael V Sivak; Deepak Agrawal; Amitabh Chak
Journal:  Gastrointest Endosc       Date:  2004-10       Impact factor: 9.427

8.  Improved stent characteristics for prophylaxis of post-ERCP pancreatitis.

Authors:  Abdullah Rashdan; Evan L Fogel; Lee McHenry; Stuart Sherman; M'Hamed Temkit; Glen A Lehman
Journal:  Clin Gastroenterol Hepatol       Date:  2004-04       Impact factor: 11.382

Review 9.  Role of pancreatic stents in prevention of post-ERCP pancreatitis.

Authors:  Martin L Freeman
Journal:  JOP       Date:  2004-09-10

Review 10.  Incidence rates of post-ERCP complications: a systematic survey of prospective studies.

Authors:  Angelo Andriulli; Silvano Loperfido; Grazia Napolitano; Grazia Niro; Maria Rosa Valvano; Fulvio Spirito; Alberto Pilotto; Rosario Forlano
Journal:  Am J Gastroenterol       Date:  2007-05-17       Impact factor: 10.864

View more
  4 in total

1.  Using air cholangiography to reduce postendoscopic retrograde cholangiopancreatography cholangitis in patients with malignant hilar obstruction.

Authors:  Qi-Bin He; Ru-Hua Zheng; Yi Wang; Lei Wang; Lu-Xuan Tan; Gui-Xia Meng; Huan Zhong; Jie Duan; Ai-Dong Gu
Journal:  Quant Imaging Med Surg       Date:  2022-03

2.  The Safety and Efficacy of an Unflanged 4F Pancreatic Stent in Transpancreatic Precut Sphincterotomy for Patients with Difficult Biliary Cannulation: A Prospective Cohort Study.

Authors:  Jieun Ryu; Kyu-Hyun Paik; Chang-Il Kwon; Dong Hee Koh; Tae Jun Song; Seok Jeong; Won Suk Park
Journal:  J Clin Med       Date:  2022-09-26       Impact factor: 4.964

3.  Fluid type and volume reduce risk of post-ERCP pancreatitis and length of hospital stay in high-risk patients: a secondary analysis of the INDIEH trial.

Authors:  Rupjyoti Talukdar; Ayesha Kamal; Venkata S Akshintala; Rajesh Goud; Sundeep Lakhtakia; Mohan K Ramchandani; Manu Tandan; G V Rao; Zaheer Nabi; Rajesh Gupta; Rakesh Kalapala; Jahangeer Basha; Manohar Reddy; Vijay K Rai; Mahesh K Goenka; Saroj Sinha; Rakesh Kochhar; B Joseph Elmunzer; Mouen A Khashab; Anthony N Kalloo; Vikesh K Singh; D Nageshwar Reddy
Journal:  Endosc Int Open       Date:  2020-06-16

4.  Increased Use of Prophylactic Measures in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.

Authors:  Christina J Sperna Weiland; Megan M L Engels; Alexander C Poen; Abha Bhalla; Niels G Venneman; Jeanin E van Hooft; Marco J Bruno; Robert C Verdonk; Paul Fockens; Joost P H Drenth; Erwin J M van Geenen
Journal:  Dig Dis Sci       Date:  2021-02-25       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.